Your browser doesn't support javascript.
loading
Characterization of novel neutralizing mouse monoclonal antibody JM1-24-3 developed against MUC18 in metastatic melanoma.
Feng, Runhua; Wang, Yuling; Ramachandran, Vijaya; Ma, Qinhong; May, Matthew M; Li, Ming; Zhou, Joe X; Xu, Xiang; Xu, Kejing; Fang, Shenying; Xia, Weiya; Sui, Dawen; Liu, Huey; Gao, Xiaolian; Prieto, Victor; Blacklow, Stephen C; Lu, Mason; Lee, Jeffrey E.
Afiliação
  • Feng R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Wang Y; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Ramachandran V; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Ma Q; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • May MM; MedAbome, Inc., Fremont, CA, 94538, USA.
  • Li M; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Zhou JX; Department of Otolaryngology, Mayo School of Graduate Medical Education, Rochester, MN, 55905, USA.
  • Xu X; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Xu K; Department of Pathology, Anhui Province Hospital, Anhui Medical University, Hefei, Anhui, 230032, China.
  • Fang S; LC Sciences, LLC, Houston, TX, 77054, USA.
  • Xia W; Department of Biological Chemistry and Molecular Pharmacology, Harvard University School of Medicine, Boston, MA, 02115, USA.
  • Sui D; Department of Pathology, UT Southwestern Medical Center, Dallas, TX, 75390, USA.
  • Liu H; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Gao X; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Prieto V; Department of Molecular & Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Blacklow SC; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Lu M; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Lee JE; Department of Biology and Biochemistry, The University of Houston, Houston, TX, 77204, USA.
J Exp Clin Cancer Res ; 39(1): 273, 2020 Dec 05.
Article em En | MEDLINE | ID: mdl-33278894
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Melanoma / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Animals / Humans / Male Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Melanoma / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Animals / Humans / Male Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido